Home
>
National Drug Code (NDC)
>
VELCADE
VELCADE - 63020-049-01 - (bortezomib)
Drug Information of VELCADE
| Product NDC: | 63020-049 |
| Proprietary Name: | VELCADE |
| Non Proprietary Name: | bortezomib |
| Active Ingredient(s): | 3.5 mg/1 & nbsp; bortezomib |
| Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of VELCADE
| Product NDC: | 63020-049 |
| Labeler Name: | Millennium Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021602 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20030513 |
Package Information of VELCADE
| Package NDC: | 63020-049-01 |
| Package Description: | 1 VIAL in 1 CARTON (63020-049-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (63020-049-04) |
NDC Information of VELCADE
| NDC Code | 63020-049-01 |
| Proprietary Name | VELCADE |
| Package Description | 1 VIAL in 1 CARTON (63020-049-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (63020-049-04) |
| Product NDC | 63020-049 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | bortezomib |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20030513 |
| Marketing Category Name | NDA |
| Labeler Name | Millennium Pharmaceuticals, Inc. |
| Substance Name | BORTEZOMIB |
| Strength Number | 3.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Proteasome Inhibitor [EPC],Proteasome Inhibitors [MoA] |
